🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Bill McDermott

2 posts
Read More

ServiceNow (NYSE: NOW) raises AI contract target to $1.7bn, but shares plunge 17% after hours

ServiceNow reported 21% subscription revenue growth and raised its AI annual contract value target, but sharply lower GAAP margins and rising acquisition-related costs complicated the earnings picture. The results highlight the difference between commercial AI momentum and the profitability investors can expect from the expanded business.